Everest Medicines Expands Strategic Investment in I-MAB
– Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash in I-Mab. Inclusive of I-MAB shares already held by Everest, the pro forma ownership will be 16.1%.
&… อ่านเพิ่ม